172 related articles for article (PubMed ID: 24733693)
21. FDA notifications. FDA published 2 new rules regarding INDs.
AIDS Alert; 2009 Nov; 24(11):130-1. PubMed ID: 19967790
[No Abstract] [Full Text] [Related]
22. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
23. Development of PET probes for cancer imaging.
Huang R; Wang M; Zhu Y; Conti PS; Chen K
Curr Top Med Chem; 2015; 15(8):795-819. PubMed ID: 25732787
[TBL] [Abstract][Full Text] [Related]
24. Innovative early development regulatory approaches: expIND, expCTA, microdosing.
Robinson WT
Clin Pharmacol Ther; 2008 Feb; 83(2):358-60. PubMed ID: 18091759
[TBL] [Abstract][Full Text] [Related]
25. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
26. The new drug approvals of 1990, 1991, and 1992: trends in drug development.
Kaitin KI; Manocchia M; Seibring M; Lasagna L
J Clin Pharmacol; 1994 Feb; 34(2):120-7. PubMed ID: 8163711
[TBL] [Abstract][Full Text] [Related]
27.
Carlucci G; Ippisch R; Slavik R; Mishoe A; Blecha J; Zhu S
J Nucl Med; 2021 Feb; 62(2):149-155. PubMed ID: 33443068
[TBL] [Abstract][Full Text] [Related]
28. Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance.
Zhu S; Mosessian S; Kroeger K; Sadeghi S; Slavik R; Kinloch S; Moore M; Allen-Auerbach M; Czernin J; Phelps M
Mol Imaging Biol; 2020 Apr; 22(2):256-264. PubMed ID: 31240531
[TBL] [Abstract][Full Text] [Related]
29. Information needed to conduct first-in-human oncology trials in the United States: a view from a former FDA medical reviewer.
Senderowicz AM
Clin Cancer Res; 2010 Mar; 16(6):1719-25. PubMed ID: 20215544
[TBL] [Abstract][Full Text] [Related]
30. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
31. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
Schwarzenberg J; Radu CG; Benz M; Fueger B; Tran AQ; Phelps ME; Witte ON; Satyamurthy N; Czernin J; Schiepers C
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):711-21. PubMed ID: 21127859
[TBL] [Abstract][Full Text] [Related]
32. RU 486, the FDA and free enterprise.
Buc NL
Law Med Health Care; 1992; 20(3):224-5. PubMed ID: 1434765
[TBL] [Abstract][Full Text] [Related]
33. The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience.
Carpenter AP; Pontecorvo MJ; Hefti FF; Skovronsky DM
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):387-93. PubMed ID: 19834448
[TBL] [Abstract][Full Text] [Related]
34. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
35. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
Food and Drug Administration. HHS
Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
[TBL] [Abstract][Full Text] [Related]
36. Analysis of secondary pharmacology assays received by the US Food and Drug Administration.
Scott C; Dodson A; Saulnier M; Snyder K; Racz R
J Pharmacol Toxicol Methods; 2022; 117():107205. PubMed ID: 35926773
[TBL] [Abstract][Full Text] [Related]
37. Novel PET probes specific for deoxycytidine kinase.
Shu CJ; Campbell DO; Lee JT; Tran AQ; Wengrod JC; Witte ON; Phelps ME; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2010 Jul; 51(7):1092-8. PubMed ID: 20554721
[TBL] [Abstract][Full Text] [Related]
38. 2016 FDA drug approvals.
Mullard A
Nat Rev Drug Discov; 2017 Feb; 16(2):73-76. PubMed ID: 28148938
[No Abstract] [Full Text] [Related]
39. Operation of a radiopharmacy for a clinical trial.
Norenberg JP; Petry NA; Schwarz S
Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
[TBL] [Abstract][Full Text] [Related]
40. Significant FDA approvals in 1997.
Rheinstein PH; Akbari B
Am Fam Physician; 1998 Jun; 57(11):2865-8. PubMed ID: 9636343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
